Preparation, quality control and biological evaluation of 99mTc-labelled cationic steroid antibiotic (CSA-13)

Radiochimica Acta

Volumn 97, Issue 1, 2009, Pages 57-62

  Roohi, S ^a   Amir, N ^a   Mushtaq, A ^a   Savage, P B ^b   Salahuddin, S M ^a   Jehangir, M ^a  

^a PAKISTAN INSTITUTE OF NUCLEAR SCIENCE AND TECHNOLOGY   (Pakistan)

^b Brigham Young University   (United States)

Author keywords

99mTc CSA; Biodistribution; CSA 13; Infection; Labelling; S. aureus

Indexed keywords

EID: 65349145760     PISSN: 00338230     EISSN: None     Source Type: Journal    
DOI: 10.1524/ract.2009.1572     Document Type: Article

References (19)

1. Savage, P. B., Li, C., Taotafa, U., Ding, B., Guan, Q.: Antibacterial properties of cationic steroid antibiotics. Federation of European Microbiological Societies (FEMS). Microbiol. Lett. 217, 1 (2002).
2. Li, C., Lewis, M. R., Gilbert, A. B., Noel, M. D., Scoville, D. H., Allman, G. W., Savage, P. B.: Antimicrobial activities of amine and guanidine-functionalized cholic acid derivatives. Antimicrob. Agents Chemother. 43, 1347 (1999).
3. Schmidt, E. J., Boswell, S. R., Walsh, J. P., Schellenberg, M. M, Winter, T. W., Li,C., Allman, G. W., Savage, P. B.: Activities of cholic acid-derived antimicrobial agents against multidrug-resistant bacteria. J. Antimicrob. Chemother. 47, 671 (2001).
4. Ding, B., Guan, Q., Walsh, J. P., Winter, T. W., Winter, T. S., Boyd, S. S., Li, C., Savage, P. B.: Correlation of the antibacterial activities of the cationic peptide antibiotics and cationic steroid antibiotics. J. Med. Chem. 45, 663 (2002).
5. Chu, W. L: Ceragenix drug compound found to kill HIV strains. www.ceragenix.com.
6. Savage, P. B.: Design synthesis and characterization of cationic peptide and steroid antibiotics. Eur. J. Org. Chem. 5, 759 (2002).
7. 99mTc-kanamycin. J. Ra-dioanal. Nucl. Chem. 267, 561 (2006).
8. Roohi, S., Mushtaq, A., Jehangir, M., Malik, S. A.: Direct labelling of isoniazid with technetium-99m for diagnosis of tuberculosis. Radiochim. Acta 94, 147 (2006).
9. 99mTc-vancomycin. Radiochim. Acta 93, 415 (2005).
10. Welling, M. M., Paulusma-Annema, A., Baiter, H. S., Pauwels, E. K. J., Nibbering, P. H.: Localization of bacterial infection with technetium-99m labelled human IgG: Further improvement with enriched IgG subclass preparation. Eur. J. Nucl. Med. 27, 292 (2000).
11. 99mTc-HMPAO leukocyte scintigraphy. J. Nucl. Med. 42, 567 (2001).
12. 99mTc-infecton imaging with radiolabeled white-cell imaging in the evaluation of bacterial infection. Eur. J. Nucl. Med. 347, 233 (1996).
13. Oh, S. J.,Ryu, J. S., Shin, J. W., Yoon, E. J., Ha, H. J., Cheon, J. H.: Inorganic radiopharmaceuticals. Appl. Radiat. Isot. 57, 193 (2002).
14. Obradovic, V., Artiko, V., Petrovic, N., Davidovic, B., Nikolic, N., Vucetic, C., Sobic-Saranovic, D., Todorovic-Tirnanic, M., Vlaj-kovic, M.: Preliminary results of imaging orthopaedic infections with Tc-99m ciprofloxacin using a newly developed simple labelling. World J. Nucl. Med. 2, 269 (2003).
15. Cron, M. J., Fardig,0. B., Johnson, D. L., Palermiti,F. M., Schmitz, H., Hooper, I. R.: Chemistry of kanamycin. Ann. NY Acad. Sci. 76, 27 (1958).
16. Britton, K. E., Vinjamuri, S. A., Hall, V., Solanki, K., Siraj, Q. H.: Clinical evaluation of technetium-99m infectin for the localization of bacterial infection. Eur. J. Nucl. Med. 24, 553 (1997).
17. Das, S. S., Britton, K. E.: Bacterial specific imaging. World J. Nucl. Med. 2, 173 (2003).
18. 99mTc white blood cells and free phase bone imaging in the diagnosis of hip prosthesis infections: improved diagnostic accuracy with extended imaging time. Nucl. Med. Commun. 23, 167 (2002).
19. Corstens, F. H., Van der Meer, M. J. W. M.: Nuclear medicine's role in infection and inflammation. Lancet 354 (1997).